Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420305193 |
id |
doaj-609ed27ea41d4a1db5d191877136606c |
---|---|
record_format |
Article |
spelling |
doaj-609ed27ea41d4a1db5d191877136606c2020-12-11T04:22:30ZengElsevierEBioMedicine2352-39642020-12-0162103143Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening testTim Waterboer0Nicole Brenner1Jens P. Klussmann2Paul Brennan3Ulrike Wieland4Hilary A. Robbins5Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Corresponding author.Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, GermanyGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, FranceNational Reference Center for Papilloma- and Polyomaviruses, University of Cologne, Cologne, GermanyGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, Francehttp://www.sciencedirect.com/science/article/pii/S2352396420305193 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tim Waterboer Nicole Brenner Jens P. Klussmann Paul Brennan Ulrike Wieland Hilary A. Robbins |
spellingShingle |
Tim Waterboer Nicole Brenner Jens P. Klussmann Paul Brennan Ulrike Wieland Hilary A. Robbins Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test EBioMedicine |
author_facet |
Tim Waterboer Nicole Brenner Jens P. Klussmann Paul Brennan Ulrike Wieland Hilary A. Robbins |
author_sort |
Tim Waterboer |
title |
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test |
title_short |
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test |
title_full |
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test |
title_fullStr |
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test |
title_full_unstemmed |
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test |
title_sort |
study results and related evidence do not support use of hpv16 l1 drh1 antibodies as a cancer screening test |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2020-12-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2352396420305193 |
work_keys_str_mv |
AT timwaterboer studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT nicolebrenner studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT jenspklussmann studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT paulbrennan studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT ulrikewieland studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT hilaryarobbins studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest |
_version_ |
1724386899855933440 |